BCDA

BioCardia, Inc. Common Stock

1.28

USD

BCDA Earnings Reports

Positive Surprise Ratio

BCDA beat 16 of 23 last estimates.

70%

Next Report

Date of Next Report

Mar 24, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.17

Implied change from Q3 25 (Revenue/ EPS)

-29.17%

Implied change from Q4 24 (Revenue/ EPS)

-32.00%

BioCardia, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, BCDA reported earnings of -0.24 USD per share (EPS) for Q3 25, missing the estimate of -0.23 USD, resulting in a -2.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.08% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.17 USD, with revenue projected to reach -- USD, implying an decrease of -29.17% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were BioCardia, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, BioCardia, Inc. Common Stock reported EPS of -$0.24, missing estimates by -2.3%, and revenue of $0.00, 0% as expectations.

How did the market react to BioCardia, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -3.08%, changed from $1.30 before the earnings release to $1.26 the day after.

When is BioCardia, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 24, 2026.

What are the forecasts for BioCardia, Inc. Common Stock's next earnings report?

Based on 4 analysts, BioCardia, Inc. Common Stock is expected to report EPS of -$0.17 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.